Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2014

01-10-2014 | Review

Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review

Authors: Hanne Verbelen, Nick Gebruers, Tinne Beyers, Anne-Caroline De Monie, Wiebren Tjalma

Published in: Breast Cancer Research and Treatment | Issue 3/2014

Login to get access

Abstract

Breast-conserving surgery (BCS) is commonly used in breast cancer treatment. Despite its benefits, some women will be troubled by breast edema. Breast edema may cause an unsatisfactory cosmetic result, influencing the quality of life. The purpose of this systematic review is to investigate the incidence of breast edema and to identify risk factors of breast edema in breast cancer patients following BCS and radiotherapy. A systematic literature search was performed using different electronic databases (PubMed, Web of Science, Cochrane, Embase) until June 2014. Inclusion criteria were as follows: (1) research studies that included female breast cancer patients who were treated with BCS and radiotherapy and (2) studies that investigated the incidence of breast edema and/or risk factors of breast edema. Exclusion criteria were (1) reviews or case studies and (2) studies published before 1995. We identified in total 28 papers which represented 4,011 patients. There was a great variation in the incidence of breast edema (0–90.4 %). We identified several possible risk factors for breast edema namely increasing irradiated breast volume, increasing boost volume, the use of a photon boost, increasing breast separation, a higher density of the breast tissue, a large tumor, a higher specimen weight, postoperative infection, acute postoperative toxicity, and diabetes mellitus. However, their prognostic value remains uncertain. Breast edema is a common complaint after BCS and radiotherapy. A number of possible risk factors associated with breast edema were identified, but further research is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lazovich D, Solomon CC, Thomas DB, Moe RE, White E (1999) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628–637PubMedCrossRef Lazovich D, Solomon CC, Thomas DB, Moe RE, White E (1999) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628–637PubMedCrossRef
2.
go back to reference Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CMl, Lam WY, Basco VE, Jackson SM (1996) Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 41:7–13PubMedCrossRef Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CMl, Lam WY, Basco VE, Jackson SM (1996) Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 41:7–13PubMedCrossRef
3.
go back to reference Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, Lala M, Martinez A, Schell S, Vicini FA (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375–1380PubMedCrossRef Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, Lala M, Martinez A, Schell S, Vicini FA (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375–1380PubMedCrossRef
4.
go back to reference Adriaenssens N, Belsack D, Buyl R, Ruggiero L, Breucq C, De Mey J, Lievens P, Lamote J (2012) Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy. Radiol Oncol 46:284–295PubMedCrossRefPubMedCentral Adriaenssens N, Belsack D, Buyl R, Ruggiero L, Breucq C, De Mey J, Lievens P, Lamote J (2012) Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy. Radiol Oncol 46:284–295PubMedCrossRefPubMedCentral
5.
go back to reference Adriaenssens N, Verbelen H, Lievens P, Lamote J (2012) Lymphedema of the operated and irradiated breast in breast cancer patients following breast conserving surgery and radiotherapy. Lymphology 45:154–164PubMed Adriaenssens N, Verbelen H, Lievens P, Lamote J (2012) Lymphedema of the operated and irradiated breast in breast cancer patients following breast conserving surgery and radiotherapy. Lymphology 45:154–164PubMed
6.
go back to reference Toledano A, Garaud P, Serin S, Fourquet A, Bosset JF, Breteau N, Body G, Azria D, Le Floch O, Calais G (2006) Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys 65:324–332PubMedCrossRef Toledano A, Garaud P, Serin S, Fourquet A, Bosset JF, Breteau N, Body G, Azria D, Le Floch O, Calais G (2006) Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys 65:324–332PubMedCrossRef
7.
go back to reference Pezner RD, Patterson MP, Hill LR, Desai KR, Vora N, Lipsett JA (1985) Breast edema in patients treated conservatively for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 11:1765–1768PubMedCrossRef Pezner RD, Patterson MP, Hill LR, Desai KR, Vora N, Lipsett JA (1985) Breast edema in patients treated conservatively for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 11:1765–1768PubMedCrossRef
8.
go back to reference Clarke D, Martinez A, Cox RS, Goffinet DR (1982) Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer 49:2295–2299PubMedCrossRef Clarke D, Martinez A, Cox RS, Goffinet DR (1982) Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer 49:2295–2299PubMedCrossRef
9.
go back to reference Delay E, Gosset J, Toussoun G, Delaporte T, Delbaere M (2008) Post-treatment sequelae after breast cancer conservative surgery. Ann Chir Plast Esthét 53:135–152PubMedCrossRef Delay E, Gosset J, Toussoun G, Delaporte T, Delbaere M (2008) Post-treatment sequelae after breast cancer conservative surgery. Ann Chir Plast Esthét 53:135–152PubMedCrossRef
10.
go back to reference Vuorela AL, Harju E, Jakobsson M (1989) Mammographic and palpation findings in the irradiated spared breast. Anticancer Res 9:1217–1222PubMed Vuorela AL, Harju E, Jakobsson M (1989) Mammographic and palpation findings in the irradiated spared breast. Anticancer Res 9:1217–1222PubMed
11.
go back to reference Wratten CR, O’Brien PC, Hamilton CS, Bill D, Kilmurray J, Denham JW (2007) Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound. Breast J 13:266–273PubMedCrossRef Wratten CR, O’Brien PC, Hamilton CS, Bill D, Kilmurray J, Denham JW (2007) Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound. Breast J 13:266–273PubMedCrossRef
12.
go back to reference Degnim AC, Miller J, Hoskin TL, Boughey JC, Loprinzi M, Thomsen K, Maloney S, Baddour LM, Cheville AL (2012) A prospective study of breast lymphedema-frequency, symptoms, and quality of life. Breast Cancer Res Treat 134:915–922PubMedCrossRefPubMedCentral Degnim AC, Miller J, Hoskin TL, Boughey JC, Loprinzi M, Thomsen K, Maloney S, Baddour LM, Cheville AL (2012) A prospective study of breast lymphedema-frequency, symptoms, and quality of life. Breast Cancer Res Treat 134:915–922PubMedCrossRefPubMedCentral
13.
go back to reference Kelemen G, Varga Z, Lázár G, Thurzó L, Kahán Z (2012) Cosmetic outcome 1–5 years after breast conservative surgery, irradiation and systemic therapy. Pathol Oncol Res 18:421–427PubMedCrossRef Kelemen G, Varga Z, Lázár G, Thurzó L, Kahán Z (2012) Cosmetic outcome 1–5 years after breast conservative surgery, irradiation and systemic therapy. Pathol Oncol Res 18:421–427PubMedCrossRef
14.
go back to reference Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456–1461PubMedCrossRef Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456–1461PubMedCrossRef
15.
go back to reference Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, Mcmasters KM, Spanos WJ (2013) Clinical investigation : breast cancer a Phase 2 trial of once-weekly hypofractionated breast irradiation : first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys 85:123–128CrossRef Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, Mcmasters KM, Spanos WJ (2013) Clinical investigation : breast cancer a Phase 2 trial of once-weekly hypofractionated breast irradiation : first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys 85:123–128CrossRef
16.
go back to reference Formenti SC, Hsu H, Fenton-kerimian M, Roses D, Guth A, Jozsef G, Goldberg JD, Dewyngaert JK (2012) Prone accelerated partial breast irradiation after breast-conserving surgery : five-year results of 100 patients. Int J Radiat Oncol Biol Phys 84:606–611PubMedCrossRefPubMedCentral Formenti SC, Hsu H, Fenton-kerimian M, Roses D, Guth A, Jozsef G, Goldberg JD, Dewyngaert JK (2012) Prone accelerated partial breast irradiation after breast-conserving surgery : five-year results of 100 patients. Int J Radiat Oncol Biol Phys 84:606–611PubMedCrossRefPubMedCentral
17.
go back to reference Chadha M, Vongtama D, Friedmann P, Parris C, Boolbol SK, Woode R, Harrison LB (2012) Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 12:57–62PubMedCrossRef Chadha M, Vongtama D, Friedmann P, Parris C, Boolbol SK, Woode R, Harrison LB (2012) Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 12:57–62PubMedCrossRef
18.
go back to reference Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE (2011) The Cambridge Breast Intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol 23:662–673CrossRef Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE (2011) The Cambridge Breast Intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol 23:662–673CrossRef
19.
go back to reference Berrang TS, Olivotto I, Kim D-H, Nichol A, Cho BCJ, Mohamed IG, Parhar T, Wright JR, Truong P, Tyldesley S, Sussman J, Wai E, Whelan T (2011) Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int J Radiat Oncol Biol Phys 81:1220–1227PubMedCrossRef Berrang TS, Olivotto I, Kim D-H, Nichol A, Cho BCJ, Mohamed IG, Parhar T, Wright JR, Truong P, Tyldesley S, Sussman J, Wai E, Whelan T (2011) Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int J Radiat Oncol Biol Phys 81:1220–1227PubMedCrossRef
20.
go back to reference Kuzmiak CM, Zeng D, Cole E, Pisano ED (2009) Mammographic findings of partial breast irradiation. Acad Radiol 16:819–825PubMedCrossRef Kuzmiak CM, Zeng D, Cole E, Pisano ED (2009) Mammographic findings of partial breast irradiation. Acad Radiol 16:819–825PubMedCrossRef
21.
go back to reference Constantine C, Parhar P, Lymberis S, Fenton-Kerimian M, Han SC, Rosenstein BS, Formenti SC (2008) Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clin Breast Cancer 8:269–274PubMedCrossRef Constantine C, Parhar P, Lymberis S, Fenton-Kerimian M, Han SC, Rosenstein BS, Formenti SC (2008) Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clin Breast Cancer 8:269–274PubMedCrossRef
22.
go back to reference Wenz F, Welzel G, Keller A, Blank E, Vorodi F, Herskind C, Tomé O, Sütterlin M, Kraus-Tiefenbacher M (2008) Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast 17:617–622PubMedCrossRef Wenz F, Welzel G, Keller A, Blank E, Vorodi F, Herskind C, Tomé O, Sütterlin M, Kraus-Tiefenbacher M (2008) Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast 17:617–622PubMedCrossRef
23.
go back to reference Vicini FA, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, Kestin L, Schell S, Goldstein NS, Kunzman J, Gilbert S, Martinez A (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69:1124–1130PubMedCrossRef Vicini FA, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, Kestin L, Schell S, Goldstein NS, Kunzman J, Gilbert S, Martinez A (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69:1124–1130PubMedCrossRef
24.
go back to reference Mussari S, Sabino della Sala W, Busana L, Vanoni V, Eccher C, Zani B, Menegotti L, Tomio L (2006) Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182:589–595PubMedCrossRef Mussari S, Sabino della Sala W, Busana L, Vanoni V, Eccher C, Zani B, Menegotti L, Tomio L (2006) Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182:589–595PubMedCrossRef
25.
go back to reference Marcenaro M, Sacco S, Pentimalli S, Berretta L, Andretta V, Grasso R, Parodi C, Guarrera M, Scarpati D (2004) Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Tumori 90:586–591PubMed Marcenaro M, Sacco S, Pentimalli S, Berretta L, Andretta V, Grasso R, Parodi C, Guarrera M, Scarpati D (2004) Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Tumori 90:586–591PubMed
26.
go back to reference Back M (2004) Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol 16:12–16CrossRef Back M (2004) Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol 16:12–16CrossRef
27.
go back to reference Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W (2003) Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55:1013–1018PubMedCrossRef Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W (2003) Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55:1013–1018PubMedCrossRef
28.
go back to reference Lamb D, Atkinson C, Joseph D, O’Brien P, Ackland S, Bonaventura A, Dady P, Hamilton C, Spry N, Stewart J, Denham J (1999) Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australas Radiol 43:220–226PubMedCrossRef Lamb D, Atkinson C, Joseph D, O’Brien P, Ackland S, Bonaventura A, Dady P, Hamilton C, Spry N, Stewart J, Denham J (1999) Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australas Radiol 43:220–226PubMedCrossRef
29.
go back to reference Grann A, McCormick B, Chabner ES, Gollamudi SV, Schupak KD, Mychalczak BR, Heerdt AS, Merchant TE, Hunt MA (2000) Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 47:319–325PubMedCrossRef Grann A, McCormick B, Chabner ES, Gollamudi SV, Schupak KD, Mychalczak BR, Heerdt AS, Merchant TE, Hunt MA (2000) Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 47:319–325PubMedCrossRef
30.
go back to reference Fung MC, Schultz DJ, Solin LJ (1997) Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation the university of Pennsylvania experience. Int J Radiat Oncol Biol Phys 38:959–967PubMedCrossRef Fung MC, Schultz DJ, Solin LJ (1997) Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation the university of Pennsylvania experience. Int J Radiat Oncol Biol Phys 38:959–967PubMedCrossRef
31.
go back to reference Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Onel K, Ambrosone CB (2008) Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 122:1333–1339PubMedCrossRef Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Onel K, Ambrosone CB (2008) Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 122:1333–1339PubMedCrossRef
32.
go back to reference Li F, He Z, Xue M, Chen L, Wu S, Guan X (2011) Feasibility and acute toxicity of 3-dimensional conformal external-beam accelerated partial-breast irradiation for early-stage breast cancer after breast-conserving surgery in Chinese female patients. Chin Med J 124:1305–1309PubMed Li F, He Z, Xue M, Chen L, Wu S, Guan X (2011) Feasibility and acute toxicity of 3-dimensional conformal external-beam accelerated partial-breast irradiation for early-stage breast cancer after breast-conserving surgery in Chinese female patients. Chin Med J 124:1305–1309PubMed
33.
go back to reference Mayo C, Lo YC, Fitzgerald TJ, Urie M (2004) Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer. Med Dosim 29:265–270PubMedCrossRef Mayo C, Lo YC, Fitzgerald TJ, Urie M (2004) Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer. Med Dosim 29:265–270PubMedCrossRef
34.
go back to reference Goyal S, Daroui P, Khan AJ, Kearney T, Kirstein L, Haffty BG (2013) Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). Cancer Med 2:964–971PubMedCrossRefPubMedCentral Goyal S, Daroui P, Khan AJ, Kearney T, Kirstein L, Haffty BG (2013) Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). Cancer Med 2:964–971PubMedCrossRefPubMedCentral
35.
go back to reference Forrai G, Polgar C, Zana K, Riedl E, Fodor J, Nemeth G, Fornet B (2001) The role of STIR MRI sequence in the evaluation of the breast following conservative surgery and radiotherapy. Neoplasma 48:7–11PubMed Forrai G, Polgar C, Zana K, Riedl E, Fodor J, Nemeth G, Fornet B (2001) The role of STIR MRI sequence in the evaluation of the breast following conservative surgery and radiotherapy. Neoplasma 48:7–11PubMed
36.
go back to reference Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss M, Yarnold JR (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086–1094PubMedCrossRef Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss M, Yarnold JR (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086–1094PubMedCrossRef
37.
go back to reference Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40:645–650PubMedCrossRef Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40:645–650PubMedCrossRef
Metadata
Title
Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review
Authors
Hanne Verbelen
Nick Gebruers
Tinne Beyers
Anne-Caroline De Monie
Wiebren Tjalma
Publication date
01-10-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3110-8

Other articles of this Issue 3/2014

Breast Cancer Research and Treatment 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine